MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Cerebellar ataxia due to vitamin E deficiency

    N. Stojiljkovic, S. Redko, F. Gupta, S. Kathiresu Nageshwaran, W. Tse (New York, USA)

    Objective: To report the case of a young man that developed cerebellar ataxia due to vitamin E deficiency secondary to intestinal malabsorption. Background: Cerebellar ataxia…
  • 2023 International Congress

    Enhancement of deep sleep in people with Parkinson disease using auditory stimulation of slow waves at home

    SJ. Schreiner, S. Fattinger, J. Horlacher, G. da Poian, L. Kämpf, L. Brogli, W. Karlen, R. Huber, CR. Baumann, A. Maric (Zurich, Switzerland)

    Objective: To test the feasibility and effectivity of a new method for non-pharmacological enhancement of deep sleep in Parkinson disease (PD). Background: Sleep-wake disturbances and…
  • 2023 International Congress

    Targeted sequencing of regulatory regions shows potential SNVs affecting FXN gene expression in Friedreich’s ataxia patients

    V. Swarup, H. Singh, V. Kumar, D. Gupta, A. Ahuja, I. Singh, R. Rajan, A. Srivastava (New Delhi, India)

    Objective: To investigate variations in regulatory regions of the FXN gene hampering its expression in Friedreich’s Ataxia (FRDA) patients. To investigate variations in regulatory regions…
  • 2023 International Congress

    White matter hyperintensities associated with impulse control disorders in Parkinson’s disease

    G. Hernadi, G. Perlaki, M. Kovacs, D. David, G. Orsi, J. Janszky, N. Kovacs (Pécs, Hungary)

    Objective: Given the limited number of non-motor features studied in this context, our aim was to reveal the potential association between the severity of white…
  • 2023 International Congress

    Episodic ataxia type 2: a previously undescribed variant in the CACNA1A gene

    N. Chunga, K. Minks, P. Morrison (Rochester, USA)

    Objective: To describe a previously unreported variant in the CACNA1A gene in a patient with episodic ataxia type 2 (EA2) phenotype. Background: EA2 is the…
  • 2023 International Congress

    Impacts of mutations in Parkinson’s disease-related genes on telomere maintenance

    YH. Chen, CH. Lin, CK. Tseng (Taipei, Taiwan)

    Objective: To investigate the correlation between telomere length (TL) and Parkinson’s disease (PD), and whether the change in telomere biology participates in PD pathogenesis. Background:…
  • 2023 International Congress

    Two Distinctive Anatomic Location in Brain Tumor Patients with Secondary Parkinsonism Manifestation: A Serial Case Report

    Y. Diansari, S. Marisdina (Palembang, Indonesia)

    Objective: We reported  two interesting cases  report of brain tumor patients  with different anatomic  location presenting secondary parkinsonism Background: Movement disorders caused by brain tumors are rare. The literature…
  • 2023 International Congress

    Parkinson’s Disease Stigma Questionnaire (PDStigmaQuest): Development and Pilot Study of a Questionnaire for Stigma in Patients with Idiopathic Parkinson’s Disease

    V. Stopic, S. Jost, JC. Baldermann, JN. Petry-Schmelzer, G. Fink, T. Dembek, H. Dafsari, J. Kessler, M. Barbe, A. Sauerbier (Cologne, Germany)

    Objective: This pilot study aimed to develop and test a stigma questionnaire specific to patients with Parkinson’s disease (PDStigmaQuest). Background: Stigma is significant in PD.…
  • 2023 International Congress

    Targeting autophagy to identify novel modulators of Parkinson’s disease using midbrain organoids

    J. Jarazo, I. Rosety, C. Serra-Almeida, R. Marques, C. Saraiva, R. Davis, J. Schwamborn (Esch-sur-Alzette, Luxembourg)

    Objective: Natural compound libraries are a great source of new chemical molecules that could restore the altered phenotypes in patient derived cells. The objective of…
  • 2023 International Congress

    A baseline study for the first year of a diverse Parkinson’s Disease interdisciplinary clinic

    V. Armengol, M. Sarno, M. Feldman, S. Marmol, A. Alfonso, G. Dumenigo, M. Garcia-Casals, S. Munzesheimer, A. Otto, TW. Siu, D. Shpiner (Miami, USA)

    Objective: To characterize patients at a new diverse, academic Parkinson’s Disease (PD) interdisciplinary clinic (IDC). Background: PD affects patients in nearly all spheres of life,…
  • « Previous Page
  • 1
  • …
  • 39
  • 40
  • 41
  • 42
  • 43
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • #23285 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley